
Escaline (3,5-dimethoxy-4-ethoxyphenethylamine) is a psychedelic phenethylamine and the 4-ethoxy analog of mescaline — a member of the broad family of trimethoxyphenethylamine-related compounds in which one or more of mescaline's methoxy groups is replaced with longer alkoxy chains. Escaline was synthesized and characterized by Alexander Shulgin, documented in PiHKAL (1991), as part of his systematic exploration of mescaline structural modifications.
At active doses (30–75 mg), escaline produces a full psychedelic experience of 6–10 hours with rich visual phenomena, emotional depth, sensory enhancement, and the warm, "soft" psychedelic quality associated with mescaline and its analogs. Community reports describe escaline as producing a particularly open, emotionally available state — less visually aggressive than high-dose 2C-B, more empathogenic than typical LSD experiences, with a pacing and character that experienced users often describe as among the more beautiful and gentle full-dose psychedelic experiences available.
The replacement of the 4-methoxy group of mescaline with a 4-ethoxy group produces a 5–8 fold increase in 5-HT2A receptor affinity according to published data, making escaline substantially more potent than mescaline by weight while sharing its fundamental pharmacological character. The community experience with escaline, while smaller than for mainstream psychedelics, is broadly consistent with these pharmacological predictions — an experienced phenethylamine user finding escaline to be a somewhat more potent and moderately longer-duration variant on the mescaline experiential theme.
Safety at a Glance
High Risk- Threshold: 15–25 mg | Common: 35–55 mg | Strong: 55–75 mg
- Escaline is 5–8 times more potent than mescaline; do not use mescaline dose references directly
- Toxicity: General Safety Profile Escaline has no documented fatalities from direct pharmacological action. Its mescaline-analog...
- Overdose risk: Fatal overdose from Escaline alone, at doses within the typical recreational range, is extremely ...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Dosage
oral
Duration
oral
Total: 8 hrs – 12 hrsHow It Feels
The come-up begins within forty-five minutes to an hour as a soft, spreading warmth that starts in the abdomen and gradually suffuses the entire body. There is a quality of gentleness to the onset that sets the tone for the entire experience. The stomach may murmur quietly in protest, but significant nausea is uncommon. The first perceptual changes appear as a subtle enrichment of color -- greens become deeper and more luminous, blues acquire a velvety depth, and warm tones glow with soft intensity. There is an almost nostalgic quality to the visual shift, as though the world is being viewed through the lens of a cherished memory.
As the experience develops over the next ninety minutes, the visual component unfolds into a gentle, immersive psychedelic state. Colors are richly saturated with a distinctly natural palette -- the deep greens of forest canopy, the warm golds of ripe grain, the complex browns and ambers of earth and bark. Surfaces breathe with slow, organic rhythms. Geometric patterns, when they appear, take the form of flowing, rounded shapes that echo natural structures: spiraling shells, branching rivers, radiating flower petals. The visual character is unmistakably related to mescaline, sharing its earthy, organic aesthetic, though at a lower intensity that makes the experience more accessible. Closed-eye visuals present as slowly shifting kaleidoscopic arrangements in warm, saturated colors.
The headspace is warm, open, and emotionally generous. There is a pronounced empathogenic quality -- a softening of interpersonal boundaries and a heightened capacity for emotional connection that makes conversations feel unusually honest and tender. The mind is clear and unhurried, capable of reflection without compulsion. There is little anxiety, little cognitive distortion, and little of the analytical intensity that characterizes the more cerebral phenethylamines. Instead, the experience is defined by a steady, reliable warmth -- an emotional tone of quiet joy and grateful presence. Music is beautifully enhanced, and natural environments feel particularly resonant. The body is comfortable and relaxed, with a gentle heaviness in the limbs that encourages stillness without demanding it.
The duration spans six to ten hours, with a long, gentle plateau and a slow, graceful descent. The comedown is smooth and leaves behind an afterglow of emotional openness and visual sensitivity that may persist well into the following day. The aftermath is clean and restorative. Escaline reads as one of the most forgiving and emotionally nourishing members of the mescaline family -- a substance that gives generously and asks almost nothing in return.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(7)
- Bodily control enhancement— Bodily control enhancement is the subjective feeling of improved physical precision, coordination, a...
- Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
- Laughter fits— Spontaneous, uncontrollable, and often prolonged episodes of intense laughter that erupt without any...
- Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
- Pupil dilation— A visible enlargement of the pupil diameter (mydriasis) that can range from subtle widening to drama...
- Stamina enhancement— Stamina enhancement is an increase in one's ability to sustain physical and mental exertion over ext...
- Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
Tactile(1)
- Tactile enhancement— The sense of touch becomes dramatically heightened, making physical contact feel intensely pleasurab...
Cognitive & Perceptual Effects
Visual(14)
- After images— A visual phenomenon in which a faint, ghostly imprint of a previously viewed image persists in the v...
- Colour enhancement— An intensification of the brightness, vividness, and saturation of colors in the external environmen...
- Colour shifting— The visual experience of colors on objects and surfaces cycling through continuous, fluid transforma...
- Drifting— The visual experience of perceiving stationary objects, textures, and surfaces as appearing to flow,...
- External hallucination— A visual hallucination that manifests within the external environment as though it were physically r...
- Geometry— The experience of perceiving complex, ever-shifting geometric patterns superimposed over the visual ...
- Internal hallucination— Vivid, detailed visual experiences perceived within an imagined mental landscape that can only be se...
- Pattern recognition enhancement— An increased ability and tendency to perceive meaningful patterns, faces, and images within ambiguou...
- Perspective hallucination— A hallucinatory phenomenon in which the observer's visual perspective shifts from the normal first-p...
- Scenery slicing— The visual field fractures into distinct, cleanly cut sections that slowly drift apart from their or...
- Settings, sceneries, and landscapes— The perceived environment in which hallucinatory experiences take place, ranging from recognizable l...
- Symmetrical texture repetition— Textures appear to mirror and tessellate across surfaces in intricate, self-similar symmetrical patt...
- Tracers— Moving objects leave visible trails of varying length and opacity behind them, similar to long-expos...
- Transformations— Objects and scenery undergo perceived visual metamorphosis, smoothly shapeshifting into other recogn...
Cognitive(18)
- Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
- Conceptual thinking— A shift in the nature of thought from verbal, linear sentence structures to intuitive, non-linguisti...
- Deja vu— Intense, often prolonged sensation of having already experienced the current moment, common with psy...
- Delusion— A delusion is a fixed, false belief that is held with unshakeable certainty and is impervious to con...
- Empathy enhancement— A state of intensified compassion and emotional openness in which one feels deeply connected to othe...
- Immersion enhancement— A heightened capacity to become fully absorbed and engrossed in external media such as music, films,...
- Increased sense of humor— A general amplification of one's sensitivity to finding things humorous and amusing, often causing p...
- Memory suppression— A dose-dependent inhibition of one's ability to access and utilize short-term and long-term memory, ...
- Mindfulness— Mindfulness in the substance context refers to a state of heightened present-moment awareness in whi...
- Nostalgia enhancement— Intensified nostalgic feelings with enhanced emotional vividness of memories, producing deep longing...
- Novelty enhancement— A feeling of increased fascination, awe, and childlike wonder attributed to everyday concepts, objec...
- Personal bias suppression— A decrease in the personal, cultural, and cognitive biases through which one normally filters their ...
- Psychosis— Psychosis is a serious psychiatric state involving a fundamental break from consensus reality — char...
- Suggestibility enhancement— Heightened receptivity to external suggestions, ideas, and influence, commonly experienced during ps...
- Thought acceleration— The experience of thoughts occurring at a dramatically increased rate, as if the mind has been shift...
- Thought connectivity— A state in which disparate thoughts, concepts, and ideas become fluidly and spontaneously interconne...
- Time distortion— Subjective perception of time becomes dramatically altered — minutes may feel like hours, or hours p...
- Wakefulness— An increased ability to stay awake and alert without the desire to sleep. Distinct from stimulation ...
Multi-sensory(1)
- Scenarios and plots— Scenarios and plots are the narrative structures that emerge within hallucinatory states — coherent ...
Transpersonal(3)
- Ego death— A profound dissolution of the sense of self in which personal identity, memories, and the boundary b...
- Existential self-realization— A sudden, visceral realization of the profound significance and improbability of one's own existence...
- Unity and interconnectedness— A profound sense that identity extends beyond the self to encompass other people, nature, or all of ...
Pharmacology
Mechanism of Action
Escaline acts as a partial agonist at serotonin 5-HT2A receptors. Notably, escaline's agonist activity at 5-HT2A has been measured at 5–8 times greater than that of mescaline in published studies — one of the more precisely characterized potency relationships within the mescaline analog family.
4-Ethoxy Substitution Effects
Replacing mescaline's 4-methoxy group with a 4-ethoxy (ethyl ether) group:
- Significantly increases 5-HT2A receptor affinity (5–8-fold by published data)
- Increases lipophilicity relative to mescaline, enhancing CNS penetration
- Resists CYP450-mediated O-dealkylation more than a methoxy group, contributing to the extended duration
- Maintains the fundamental phenethylamine structure responsible for mescaline's relatively selective 5-HT2A engagement
Comparison to Mescaline
The experiential character of escaline is closely related to mescaline — the 4-position modification does not fundamentally alter the receptor mechanism but enhances affinity and metabolic stability. Users transitioning from mescaline to escaline should expect qualitatively similar but meaningfully more potent effects at substantially lower doses.
Duration
The 6–10 hour duration of escaline is comparable to mescaline (8–12 hours) but slightly shorter. The ethoxy group's resistance to O-demethylation is somewhat less than the fully methoxy-substituted mescaline, potentially accounting for the modest duration reduction.
Detection Methods
Urine Detection
Escaline is a substituted mescaline analog belonging to the phenethylamine class. It is not targeted by standard immunoassay-based urine drug screens. Due to its phenethylamine structure, there is a theoretical possibility of cross-reactivity with amphetamine immunoassays, though this has not been well-characterized. Specialized LC-MS/MS methods can detect Escaline and its metabolites in urine for approximately 24 to 72 hours after ingestion. Limited published pharmacokinetic data exists for this compound.
Blood and Serum Detection
Blood detection windows for Escaline are estimated at 6 to 18 hours after oral administration. Peak plasma concentrations likely occur 1 to 3 hours post-ingestion based on the pharmacological onset profile. LC-MS/MS is required for reliable blood quantification.
Standard Drug Panel Inclusion
Escaline is NOT included on standard 5-panel, 10-panel, or 12-panel drug screens. Cross-reactivity with amphetamine immunoassays is possible but inconsistent. Confirmatory testing would resolve any presumptive positive. Detection requires specific novel psychoactive substance testing at a reference laboratory.
Confirmatory Methods
LC-MS/MS or GC-MS with appropriate reference standards is required for definitive identification. Few routine clinical or forensic laboratories maintain validated methods for mescaline analogs, making detection uncommon outside of specialized research or forensic contexts.
Reagent Testing (Harm Reduction)
The Marquis reagent produces a variable reaction with Escaline, typically orange to brown. The Mecke reagent may show yellow-green to brown reactions. The Ehrlich reagent shows NO reaction, distinguishing it from tryptamines and lysergamides. The Mandelin reagent produces variable color changes depending on the specific compound. Multiple reagents should be used together for field identification. Accurate dosing information is important as potency varies significantly between mescaline analogs.
Interactions
| Substance | Status | Note |
|---|---|---|
| 3-FMA | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 4-MMC | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 8-Chlorotheophylline | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Adrafinil | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Anandamide | Caution | Cannabis can unpredictably intensify psychedelic effects and increase anxiety |
| Cannabis | Uncertain | — |
| 1,3-Butanediol | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 25E-NBOH | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 2C-T | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 2C-T-2 | Low Risk & Synergy | Cross-tolerance exists; effects compound |
History
Development and PiHKAL
Escaline was synthesized by Alexander Shulgin as part of his program of systematic modification of mescaline's 4-methoxy group. The family of 4-alkoxy mescaline analogs — including escaline (4-ethoxy), proscaline (4-propoxy), allylescaline (4-allyloxy), and others — reflects Shulgin's interest in understanding which structural features of mescaline were responsible for its psychedelic character and how they could be tuned.
PiHKAL documents escaline with both synthesis procedures and Shulgin's personal bioassay notes, describing it as producing a full and warm psychedelic experience with characteristics consistent with the mescaline-class character.
Community Reports
Community experience reports for escaline, while fewer in number than for mainstream psychedelics, are consistent in describing a warm, emotionally open, visually rich experience. The 35mg Escaline First Trip report that circulates in the psychedelic community describes this character clearly — the transition from anxiety to an intensely beautiful emotional openness that users associate specifically with the mescaline-analog pharmacological family.
Legal Status
Escaline is controlled in Belgium and subject to analogue acts in most other jurisdictions. Its explicit scheduling status varies by country.
Harm Reduction
Dose Reference
- Threshold: 15–25 mg | Common: 35–55 mg | Strong: 55–75 mg
- Escaline is 5–8 times more potent than mescaline; do not use mescaline dose references directly
- The 35mg first-experience reports in the community suggest this is a reasonable starting point for someone with mescaline familiarity
Allow a Full Day
The 6–10 hour active window plus come-down means a full day should be cleared. The experience is long even by psychedelic standards.
Prepare for Emotional Depth
The empathogenic, emotionally open quality of escaline means that setting up an experience to support emotional processing — comfortable environment, trusted company if desired, journaling materials available — is particularly worthwhile.
Nausea
Nausea during the come-up is documented in community reports. A light stomach and ginger tea are reasonable precautions.
Dangerous Combinations
Toxicity & Safety
General Safety Profile
Escaline has no documented fatalities from direct pharmacological action. Its mescaline-analog structure places it within a class with historically good acute safety records at typical doses. The well-characterized 5-HT2A mechanism without significant monoamine releasing activity keeps acute physiological toxicity risks low.
Cardiovascular
Mild sympathomimetic effects — modest tachycardia and blood pressure elevation — are expected. Less pronounced than with stimulant-forward phenethylamines like 2C-I.
Duration
The 6–10 hour duration is a physiological commitment. Sustained effects over this timeframe require corresponding preparation and recovery time.
Psychological Risks
Standard psychedelic risk profile: acute anxiety/panic at higher doses, potential for psychosis precipitation in vulnerable individuals, integration challenges.
Regulatory Note
Escaline was prohibited in Belgium under the New Psychoactive Substances Act as of November 26, 2016, reflecting regulatory attention to mescaline analogs in European jurisdictions.
Drug Interactions
Addiction Potential
not habit-forming
Overdose Information
Fatal overdose from Escaline alone, at doses within the typical recreational range, is extremely unlikely based on the available evidence for classical psychedelics. The therapeutic index for most psychedelics is very wide.
However, psychological emergencies can occur and require appropriate response:
- Severe anxiety, panic, or psychotic episodes
- Dangerous behavior due to impaired reality testing
- Self-harm in the context of a distressing experience
Emergency management: If someone is experiencing a severe adverse reaction, move them to a calm, quiet environment. Speak reassuringly. Do not restrain unless there is immediate danger. Benzodiazepines (if available and the person is conscious and able to swallow) can reduce acute anxiety. If psychotic symptoms, self-harm risk, or medical distress is present, seek emergency medical attention.
Medical attention: Seek help immediately for seizures, extremely elevated body temperature, signs of serotonin syndrome (agitation, tremor, diarrhea, rapid heart rate), or if the substance consumed is uncertain.
Tolerance
| Full | almost immediately after ingestion |
| Half | 3 days |
| Zero | 7 days |
Cross-tolerances
Legal Status
Germany: Escaline is controlled under the NpSG (New Psychoactive Substances Act) as of November 26, 2016. Production and import with the aim to place it on the market, administration to another person, placing it on the market and trading is punishable. Possession is illegal but not punishable. The legislator considers it possible that orders of escaline are punishable as an incitement to place it on the market.
Japan: Escaline is a controlled substance in Japan effective December 21st, 2016.
Switzerland: Escaline is a controlled substance specifically named under Verzeichnis E.
United Kingdom: It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.
United States: Escaline is unscheduled in the U.S. but may be illegal via the Federal Analogue Act.
Responsible use
Research chemical
Psychedelics
Phenethylamine
Escaline (Wikipedia)
Escaline (PiHKAL / Isomer Design)
Experience Reports (3)
Tips (6)
Do not combine Escaline with lithium (seizure risk), tramadol (seizure/serotonin syndrome risk), or cannabis at higher doses unless very experienced. Cannabis dramatically intensifies and can destabilize a psychedelic experience.
If you experience anxiety or thought loops on Escaline, change your physical environment: move to a different room, go outside, change the music, or hold something cold. A change of scenery can instantly shift a difficult headspace.
Escaline is the 4-ethoxy analogue of mescaline with 5-8 times greater potency at the 5-HT2A receptor. At 35mg it produces a mild but distinctly psychedelic experience with subtle visual shifts, body tension, and pronounced nausea on the come-up.
Nausea and vomiting are common during the escaline come-up. Taking a hot shower immediately after vomiting can greatly relieve the muscle tension and constriction that accompanies the onset. Having ginger tea prepared beforehand also helps.
Escaline pairs exceptionally well with physical movement like yoga and dancing. The body tension that can feel uncomfortable while sitting becomes directed energy during movement, and users report a sense of ecstasy from combining the psychedelic state with rhythmic physical activity.
Have a trip sitter present, ideally someone with psychedelic experience. They should remain calm and reassuring without being intrusive. A good sitter can make the difference between a challenging experience and a genuine crisis.
Community Discussions (2)
See Also
References (5)
- Psilocybin produces substantial and sustained decreases in depression and anxiety — Griffiths et al. Journal of Psychopharmacology (2016)paper
- Neural correlates of the LSD experience revealed by multimodal neuroimaging — Carhart-Harris et al. PNAS (2016)paper
- PubChem: Escaline
PubChem compound page for Escaline (CID: 38240)
pubchem - Escaline - TripSit Factsheet
TripSit factsheet for Escaline
tripsit - Escaline - Wikipedia
Wikipedia article on Escaline
wikipedia